Table 2.
|
|
|
|
Antibodies to RHDV |
|
|
|
|
|
RHDV copies/μl bile |
||
---|---|---|---|---|---|---|---|---|---|---|---|---|
IgM |
IgA |
IgG |
cELISA |
|
||||||||
ID | Sex | Inoculation | Weight loss* | 13 dpc | 30 dpc | 13 dpc | 30 dpc | 13 dpc | 30 dpc | 13 dpc | 30 dpc | 30 dpc |
18 |
m |
infected |
Y |
+ |
– |
+ |
+ |
> 40960 |
> 40960 |
> 640 |
> 640 |
4.11E + 03 |
32 |
f |
infected |
Y |
+ |
+ |
+ |
+ |
> 40960 |
> 40960 |
> 640 |
>640 |
1.55E + 04 |
40 |
f |
contact |
N |
+ |
+ |
+ |
+ |
D |
> 40960 |
320 |
> 640 |
5.23E + 04 |
25 |
f |
contact |
N |
– |
– |
– |
D |
40 |
> 40960 |
20 |
> 640 |
2.07E + 01 |
30 |
f |
infected |
N |
– |
– |
– |
+ |
1280 |
5120 |
– |
160 |
1.70E + 01 |
11 | f | contact | N | – | – | – | – | – | 1280 | – | – | – |
Titres are expressed as the reciprocal dilutions at which the sera tested positive.
* Weight loss >10%, dpc = days post RHDV challenge, – = negative, + = positive.
D, Doubtful.